Peter H. Krammer

Active 1976–2024

196
Papers
56,322
Citations
120
h-index
192
i10-index

Citations

Citations per year for Peter H. Krammer1976: 2 citations1977: 3 citations1978: 7 citations1979: 9 citations1980: 2 citations1981: 1 citations1982: 7 citations1983: 12 citations1984: 19 citations1985: 16 citations1986: 23 citations1987: 33 citations1988: 39 citations1989: 28 citations1990: 23 citations1991: 26 citations1992: 30 citations1993: 43 citations1994: 84 citations1995: 244 citations1996: 411 citations1997: 729 citations1998: 1,074 citations1999: 1,134 citations2000: 1,112 citations2001: 985 citations2002: 866 citations2003: 1,012 citations2004: 768 citations2005: 717 citations2006: 626 citations2007: 543 citations2008: 517 citations2009: 468 citations2010: 480 citations2011: 435 citations2012: 448 citations2013: 339 citations2014: 321 citations2015: 294 citations2016: 236 citations2017: 240 citations2018: 225 citations2019: 777 citations2020: 681 citations2021: 649 citations2022: 520 citations2023: 320 citations2024: 611 citations2025: 233 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,027 citing papers, 31.9% of this breakdownGermany: 1,539 citing papers, 9.8% of this breakdownChina: 1,181 citing papers, 7.5% of this breakdownUnited Kingdom: 844 citing papers, 5.4% of this breakdownFrance: 710 citing papers, 4.5% of this breakdownJapan: 652 citing papers, 4.1% of this breakdownItaly: 566 citing papers, 3.6% of this breakdownCanada: 544 citing papers, 3.4% of this breakdownAustralia: 445 citing papers, 2.8% of this breakdownSwitzerland: 345 citing papers, 2.2% of this breakdownSpain: 309 citing papers, 2% of this breakdownSouth Korea: 307 citing papers, 1.9% of this breakdown
0%31.9%Other 20.9%

Fields

  • Biochemistry, Genetics and Molecular Biology46.4%
  • Medicine29.4%
  • Immunology and Microbiology17%
  • Neuroscience2.6%
  • Agricultural and Biological Sciences0.9%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Other2.8%

Topics

  • Cell death mechanisms and regulation11.1%
  • Immune Cell Function and Interaction4.1%
  • T-cell and B-cell Immunology3.2%
  • Cancer-related Molecular Pathways2.5%
  • NF-κB Signaling Pathways2.4%
  • Immunotherapy and Immune Responses2.4%
  • Other74.3%

Coauthors

All papers

Open in search
  1. Molecular Mechanisms of Treg-Mediated T Cell Suppression

    Authors: , , - Frontiers in Immunology 2012 cited by 767

  2. Death and anti-death: tumour resistance to apoptosis

    Authors: , - Nature reviews. Cancer 2002 cited by 2,058

  3. Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor.

    Authors: , , , , , , - The EMBO Journal 1995 cited by 2,149

  4. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex

    Authors: , , , , , , , , , , , , , - Cell 1996 cited by 3,067

  5. Mitochondrial Reactive Oxygen Species Control T Cell Activation by Regulating IL-2 and IL-4 Expression: Mechanism of Ciprofloxacin-Mediated Immunosuppression

    Authors: , , , , , , - The Journal of Immunology 2010 cited by 250

  6. Two CD95 (APO‐1/Fas) signaling pathways

    Authors: , , , , , , , , - The EMBO Journal 1998 cited by 3,001

  7. T cell Activation Is Driven by an ADP-Dependent Glucokinase Linking Enhanced Glycolysis with Mitochondrial Reactive Oxygen Species Generation

    Authors: , , , , , , , , , , , - Cell Reports 2012 cited by 198

  8. p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs

    Authors: , , , , , , , , , , - The Journal of Experimental Medicine 1998 cited by 893

  9. Regulation of CD95/Fas signaling at the DISC

    Authors: , - Cell Death and Differentiation 2011 cited by 350

  10. The CD95(APO-1/Fas) DISC and beyond

    Authors: , - Cell Death and Differentiation 2003 cited by 1,067

  11. Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis

    Authors: , , , , , , , , , , , , , - European Journal of Immunology 2005 cited by 444

  12. Life and death in peripheral T cells

    Authors: , , - Nature reviews. Immunology 2007 cited by 652

  13. Dectin-1 Binding to Annexins on Apoptotic Cells Induces Peripheral Immune Tolerance via NADPH Oxidase-2

    Authors: , , , , , , , , , - Cell Reports 2019 cited by 77

  14. FADD/MORT1 and Caspase-8 Are Recruited to TRAIL Receptors 1 and 2 and Are Essential for Apoptosis Mediated by TRAIL Receptor 2

    Authors: , , , , , , , - Immunity 2000 cited by 796

  15. Death receptor signaling

    Authors: , , - Journal of Cell Science 2005 cited by 490

  16. Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study

    Authors: , , , , , , , , , , , , , , , - Blood 2023 cited by 39

  17. The Role of c-FLIP in Modulation of CD95-induced Apoptosis

    Authors: , , , - Journal of Biological Chemistry 1999 cited by 812

  18. FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC)

    Authors: , , , , , , - The EMBO Journal 1997 cited by 1,193

  19. Novel Role for Mitochondria: Protein Kinase Cθ-Dependent Oxidative Signaling Organelles in Activation-Induced T-Cell Death

    Authors: , , , , - Molecular and Cellular Biology 2007 cited by 138

  20. Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB

    Authors: , , , , , , , , , - Blood 2016 cited by 93

  21. Mitochondria as Oxidative Signaling Organelles in T-cell Activation: Physiological Role and Pathological Implications

    Authors: , , , - Archivum Immunologiae et Therapiae Experimentalis 2013 cited by 75

  22. Stoichiometry of the CD95 Death-Inducing Signaling Complex: Experimental and Modeling Evidence for a Death Effector Domain Chain Model

    Authors: , , , , , , , , - Molecular Cell 2012 cited by 192

  23. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1

    Authors: , , , , , , , , , , - Cell Death and Disease 2011 cited by 163

  24. Prevalence of Newly Generated Naive Regulatory T Cells (Treg) Is Critical for Treg Suppressive Function and Determines Treg Dysfunction in Multiple Sclerosis

    Authors: , , , , , , , , , - The Journal of Immunology 2007 cited by 250